#coinfection

Four things you should know to be #HepAware.

A quick overview of Hep Magazine’s reporting on the 53rd International Liver Congress in Vienna

Better antiretrovirals have likely mitigated HIV’s effects on the risk of end-stage liver disease and liver cancer in those with hep C.

A research team has sought to address the critical lack of treatment guidelines for addressing HIV’s complex effects on aging.

A review of the major findings presented at the Annual Meeting of the American Association for the Study of Liver Diseases in San Francisco

Compared with their HIV-negative peers, HIV-positive individuals have higher rates of treatment for a host of health problems.

Aside from taking antiretrovirals, quitting smoking is the number one way people with HIV can lower their risk of illness and death.

Highlights from HIV and hepatitis C research presented at the 2018 Conference on Retroviruses and Opportunistic Infections (CROI) in Boston

A recent study found that daily cannabis use was associated with a reduced risk of the liver condition in this population.

Other factors linked to a reduced risk of death include a hep C cure, less advanced liver disease, not smoking and well treated HIV.